Age-related changes significantly impact natural GHK-Cu production
By then the lesion can be of quite a considerable size and since they occur in heavily sun-exposed sites, definitive treatment can be a toss-up between curative therapy with severe cosmetic defects or a less aggressive approach taking into account the likelihood of invasive disease occurring and the patients co-morbidities and age
It is often discussed alongside GLP-1 medications, although it is technically a dual GIP and GLP-1 receptor agonist, not GLP-2
During menopause, this mechanism may counteract reduced satiety signaling caused by estrogen loss, potentially restoring some appetite regulation capacity that fluctuates with hormonal changes
Hope DCD, Vincent ML, Tan TMM
Labeled "for research use only, not for human consumption." No FDA oversight on manufacturing